Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
These additions are not part of the FDA-approved formulation and may affect the reconstitution process, stability, and overall experience
Examples of the metabolic markers tracked by Calibrate include waist circumference, cholesterol, triglycerides, hemoglobin A1C (a blood test that indicates average blood sugars for the last three months), and liver enzymes
As nutrition professionals, our goal is not only to treat nutritional problems but also to educate and empower individuals to make informed choices before health complications arise